Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart Surgery

Clinical trial NCT00914589 · COMPLETED

Trial details

NCT number: NCT00914589
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acquired Bleeding Disorder Cardiac Surgery Requiring Cardiopulmonary Bypass

Start date: 2009-07-01
Primary completion: 2011-02-01
Enrollment: 479

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.